eli lilly's tirzepatide is the leader in weight loss sector Lilly was just another drug company until Zepbound and Mounjaro changed narrative. Now this trillion-dollar pharmaceutical giant trying to stay ahead of the competition bloom.bg/4enOGKz Ozempic maker Novo Nordisk sues

PPIs block acid production more aggressively

Cardoso S, Carvalho C, Correia SC, Seia RM, Moreira PI

Semaglutide is available as Ozempic (injectable), Rybelsus (oral), and over 40 DCGI-approved generics from Indian manufacturers since March 2026

[14] [15] The MHRA has issued warnings about the risks of purchasing medicines from unregulated online sources

"Prices of medicines will eventually come down sooner or later

By extending its patent protection through minor modifications, Eli Lilly seeks to maximize the lifecycle of its products while erecting as many barriers of entry for competitors as possible in order to increase the prospects of prolonging its market monopoly and profits